Omega Therapeutics Inc (OMGA)
2.41
+0.03
(+1.26%)
USD |
NASDAQ |
May 17, 16:00
2.41
0.00 (0.00%)
After-Hours: 20:00
Omega Therapeutics Profit Margin (Quarterly): -852.9% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -852.9% |
| December 31, 2023 | -2.04K% |
| September 30, 2023 | -2.68K% |
| June 30, 2023 | -3.91K% |
| March 31, 2023 | -4.90K% |
| Date | Value |
|---|---|
| December 31, 2022 | -4.19K% |
| September 30, 2022 | -4.34K% |
| June 30, 2022 | -5.44K% |
| March 31, 2022 | -7.52K% |
| December 31, 2021 | -14.48K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.48K%
Minimum
Dec 2021
-852.9%
Maximum
Mar 2024
-5.04K%
Average
-4.26K%
Median
Profit Margin (Quarterly) Benchmarks
| Fate Therapeutics Inc | -2.49K% |
| Macrogenics Inc | -573.3% |
| Ocular Therapeutix Inc | -438.9% |
| AnaptysBio Inc | -612.0% |
| Verrica Pharmaceuticals Inc | -531.4% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -117.0% |
| Return on Assets | -46.55% |
| Return on Invested Capital | -93.99% |
| Operating Margin (Quarterly) | -866.6% |
| Return on Net Operating Assets | -91.15% |